Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aspirin × Other × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 46 Breast 12 Genitourinary 10 Myeloid 9 Gynecologic 8 Classical hematology 8 Plasma cell 7 Thoracic 6 Tumor-Agnostic 4 Head & Neck 4 Other neoplasm 3 Dermatologic 3 Sarcoma 2 Other hematologic neoplasm 2 CNS 2 Other solid neoplasm 1 Other 1 Lymphoid 1

Conditions

Interventions

Exercise 25 Metformin 19 Surveys and Questionnaires 15 Methods 12 Early Intervention, Educational 12 Radiotherapy 11 Counseling 11 naloxegol 10 Standard of Care 10 Educational Status 10 Tirzepatide 8 Psychiatric Rehabilitation 8 Nutrition Assessment 8 Diet Therapy 8 Diet 8 Therapeutics 7 Resistance Training 7 Interviews as Topic 7 Cisplatin 7 alvimopan 6 Caloric Restriction 6 semaglutide 5 Radiation 5 Liraglutide 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5 Blood Specimen Collection 5 Bariatric Surgery 5 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡